Based on data from the FEMINA study, this communication aims to explore inequalities in HPV vaccine uptake. Results highlighted differences between the Portuguese and the Cape Verdean women: 97% vs. 67% had heard about the HPV vaccine; 30% vs. 9% had been vaccinated, and 71% vs. 82% had reported a lack of medical recommendation as a major reason for not having been vaccinated. Further research on the mechanisms that operate in the production of health disparities is needed to promote equity-focused interventions.info:eu-repo/semantics/publishedVersio
Background: Cervical cancer disproportionately affects women from lower socio-economic backgrounds. ...
Objective: To examine cultural barriers and participant solutions regarding acceptance and uptake o...
Introduction: Human papillomavirus (HPV) vaccination is the most effective prevention measure agains...
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article dis...
Background: In the Netherlands, human papillomavirus (HPV) vaccination is part of a national program...
Background: In the Netherlands, human papillomavirus (HPV) vaccination is part of a national program...
Background The human papillomavirus (HPV) vaccine offers an opportunity to reduce health inequalitie...
Background: Although uptake of Human Papillomavirus (HPV) vaccine is high in the United Kingdom, it ...
Objective: We investigated whether Latina mothers who were and were not human papillomavirus (HPV) p...
INTRODUCTION: Data on epidemiology of HPV infection are needed for the development of human papillo...
Two human papillomavirus (HPV) vaccines are available and can prevent 98% of HPV 16 and 18 infection...
Background: Human papillomavirus (HPV) vaccination coverage in the Netherlands is low (~60%) compare...
BACKGROUND: To identify the barriers and facilitators to uptake of the HPV vaccine in an ethnically ...
Background: In 2015, only 42% of Puerto Rican (PR) girls aged 13-17 and 44% of U.S. Hispanic girls a...
OBJECTIVE: Human papillomavirus (HPV) is responsible for a range of diseases, including cervical ca...
Background: Cervical cancer disproportionately affects women from lower socio-economic backgrounds. ...
Objective: To examine cultural barriers and participant solutions regarding acceptance and uptake o...
Introduction: Human papillomavirus (HPV) vaccination is the most effective prevention measure agains...
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article dis...
Background: In the Netherlands, human papillomavirus (HPV) vaccination is part of a national program...
Background: In the Netherlands, human papillomavirus (HPV) vaccination is part of a national program...
Background The human papillomavirus (HPV) vaccine offers an opportunity to reduce health inequalitie...
Background: Although uptake of Human Papillomavirus (HPV) vaccine is high in the United Kingdom, it ...
Objective: We investigated whether Latina mothers who were and were not human papillomavirus (HPV) p...
INTRODUCTION: Data on epidemiology of HPV infection are needed for the development of human papillo...
Two human papillomavirus (HPV) vaccines are available and can prevent 98% of HPV 16 and 18 infection...
Background: Human papillomavirus (HPV) vaccination coverage in the Netherlands is low (~60%) compare...
BACKGROUND: To identify the barriers and facilitators to uptake of the HPV vaccine in an ethnically ...
Background: In 2015, only 42% of Puerto Rican (PR) girls aged 13-17 and 44% of U.S. Hispanic girls a...
OBJECTIVE: Human papillomavirus (HPV) is responsible for a range of diseases, including cervical ca...
Background: Cervical cancer disproportionately affects women from lower socio-economic backgrounds. ...
Objective: To examine cultural barriers and participant solutions regarding acceptance and uptake o...
Introduction: Human papillomavirus (HPV) vaccination is the most effective prevention measure agains...